Product Liability vs Completed Operations (within GL) for HealthTech Startups

The decision framework: Product Liability vs Completed Operations (within GL) for HealthTech Startups

Most HealthTech Startups need both Product Liability and Completed Operations (within GL) in the policy stack rather than choosing one over the other. The decision is rarely "which one?" — it's "what limits on each?"

The exception: HealthTech Startups with operations that clearly fall on one side of the Product Liability-Completed Operations (within GL) boundary (entirely operational or entirely advisory, entirely owned-fleet or entirely employee-vehicles, etc.) may need only one coverage. For most emerging-industry operations, however, both exposures exist and both coverages are warranted.

Which policy responds to which HealthTech Startups claim?

Most HealthTech Startups claims clearly belong to one policy or the other. The exceptions — claims that genuinely span both — are usually handled through carrier-to-carrier coordination rather than the healthtech startup having to choose.

The key is reporting promptly to both carriers when a claim might involve either policy. Late reporting to one carrier can produce coverage issues; reporting to both preserves both policies' ability to respond if facts develop.

How do HealthTech Startups Product Liability and Completed Operations (within GL) premiums compare?

Product Liability and Completed Operations (within GL) typically price differently for HealthTech Startups because the underlying exposures and loss patterns differ. The relative premium reflects what carriers expect to pay out on each line over time; the more severe the expected losses, the higher the premium.

For most HealthTech Startups, the two lines together represent meaningfully different premium contributions to the total commercial insurance cost. Understanding which line is the larger cost driver helps prioritize risk-management investment toward the highest-leverage area.

Product Liability-Completed Operations (within GL) myths

HealthTech Startups who treat Product Liability and Completed Operations (within GL) as interchangeable usually end up with coverage gaps. The lines exist as separate products because the underlying exposures are different; collapsing them produces incomplete protection.

The right mental model: Product Liability and Completed Operations (within GL) are tools that solve different problems. Both belong in the toolkit. Trying to use one for the other's job typically fails — sometimes silently, until a claim exposes the gap.

Coordinating limits between Product Liability and Completed Operations (within GL) on HealthTech Startups

For HealthTech Startups carrying both Product Liability and Completed Operations (within GL), limit coordination matters. Both policies should have limits sized to the realistic exposure on their respective sides, with umbrella coverage stacking above both for catastrophic-scenario protection.

Common mistake: sizing limits based on contract minimums alone rather than realistic loss exposure. Contract minimums are floors; the realistic limit should reflect actual claim potential, which often exceeds the contract minimum.

Is there ever a case to skip Product Liability or Completed Operations (within GL)?

The case for buying only one of Product Liability or Completed Operations (within GL) on HealthTech Startups is narrow. It generally requires the healthtech startup to demonstrate that the operational exposure is genuinely one-sided — either no operational exposure (where Completed Operations (within GL) would cover everything that matters) or no advisory/financial exposure (where Product Liability would cover everything that matters).

This determination should be made with a broker who can review the operations and contractual obligations. Self-assessment often misses subtle exposures that warrant both coverages.

How HealthTech Startups efficiently buy both coverages together

For HealthTech Startups carrying both Product Liability and Completed Operations (within GL), placing both with the same carrier typically captures 5-12% multi-line credit and simplifies renewal. The premium savings often exceed the modest convenience of separate placements.

The exception: when specialty knowledge in one line favors a different carrier. If one carrier writes the best Product Liability for emerging-industry but another writes the best Completed Operations (within GL), splitting may produce better total coverage even without the multi-line credit. Most HealthTech Startups, however, find one carrier that writes both lines competitively.